Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

More research needed to confirm finasteride as standard treatment for FFA.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

Oral finasteride may cause more sexual side effects than expected, possibly due to negative publicity and reporting bias.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.